<DOC>
	<DOCNO>NCT01958060</DOCNO>
	<brief_summary>Investigation safety tolerability BI 1034020 healthy male volunteer follow intravenous ( IV ) infusion subcutaneous ( SC ) injection single dose exploration pharmacokinetics pharmacodynamics BI 1034020 single dose determination bioavailability subcutaneous injection BI 1034020</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetic Pharmacodynamic Study Single Escalating Doses BI 1034020 Administered Intravenously Subcutaneously Male Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : 1 . Healthy male base upon complete medical history , include physical examination , vital sign ( blood pressure , pulse rate ) , 12lead electrocardiogram , clinical laboratory test 2 . Age within range 18 40 year 3 . Body mass index within range 18.5 29.9 kg/m2 4 . Signed date write informed consent prior admission study accordance GCP local legislation . Exclusion criterion : 1 . Any finding medical examination ( include blood pressure , pulse rate electrocardiogram ) deviate normal judge clinically relevant investigator . Pulse rate outside range 5090 bpm blood pressure outside range 90140 systolic 5090 mmHg diastolic blood pressure confirm repeat measurement 2 . Any evidence clinically relevant concomitant disease . 3 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder . 4 . Surgery gastrointestinal tract ( except appendectomy ) . 5 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder . 6 . History relevant orthostatic hypotension , faint spell blackout . 7 . Chronic relevant acute infection .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>